CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology Vol. 41; no. S2; pp. 41 - 43
Main Authors: Illerhaus, G., Ferreri, A., Binder, M., Borchmann, P., Hasenkamp, J., Stilgenbauer, S., Roeth, A., Weber, T., Egerer, G., Ernst, T., Hertenstein, B., Lenz, G., Kobbe, G., Brunnberg, U., Schmidt, C., Kneba, M., Dreyling, M., Möhle, R., Panse, J., Heinicke, T., Schroll, S., Larsen, T. S., Salwender, H., Naumann, R., Hess, G., Thurner, L., Pukrop, T., Keller, U., Blystadt, A. K., Kroschinsky, F. P., Re, F., Pulczynski, E., Orsucci, L., Pospiech, L., Deckert, M., Ponzoni, M., Wendler, J., Valk, E., Calimeri, T., Kasenda, B., Trepel, M., Fricker, H., Gottberg, P., Burger, E., Ihorst, G., Grishina, O., Hader, C., Zucca, E., Finke, J., Schorb, E.
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-06-2023
Subjects:
Immunotherapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3163_15